Dopaminergic modulation of visual-spatial working memory in Parkinson's disease

Alberto Costa, Antonella Peppe, Grazia Dell'Agnello, Giovanni Augusto Carlesimo, Luigi Murri, Ubaldo Bonuccelli, Carlo Caltagirone

Research output: Contribution to journalArticle

Abstract

Visual-spatial working memory (WM) impairment is frequently associated with the early stage of Parkinson's disease (PD). The aim of this study was to evaluate the performance of a group of PD patients in visual-spatial and visual-object WM tasks and to investigate the effect of administering the dopaminergic agonist apomorphine (experiment 1) or the dopamine precursor L-dopa (experiment 2) on the performance of tests assessing these functions. To study WM processes, the PD patients and age-matched normal controls were given an n-back task paradigm. In both experiments, the PD patients were submitted to two evaluations: one after a 12-hour therapy washout and the other 15 min after a subcutaneous infusion of apomorphine (average 0.04 mg/kg) or 20/30 min after L-dopa intake (200 mg p.o.). The apomorphine infusion had a worsening effect on reaction times in both visual-spatial and visual-object WM tasks, but it did not influence performance accuracy. Instead, L-dopa administration had a ameliorative effect on accuracy and reaction times in both visual-spatial and visual-object tasks. These results highlight the role of dopamine in the modulation of the WM function in PD patients. Copyright

Original languageEnglish
Pages (from-to)55-66
Number of pages12
JournalDementia and Geriatric Cognitive Disorders
Volume15
Issue number2
DOIs
Publication statusPublished - 2003

Fingerprint

Short-Term Memory
Parkinson Disease
Apomorphine
Levodopa
Reaction Time
Dopamine
Subcutaneous Infusions
Dopamine Agonists
Spatial Memory
Therapeutics

Keywords

  • Apomorphine
  • Dopamine
  • Levodopa
  • Parkinson's disease
  • Working memory

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Geriatrics and Gerontology

Cite this

Dopaminergic modulation of visual-spatial working memory in Parkinson's disease. / Costa, Alberto; Peppe, Antonella; Dell'Agnello, Grazia; Carlesimo, Giovanni Augusto; Murri, Luigi; Bonuccelli, Ubaldo; Caltagirone, Carlo.

In: Dementia and Geriatric Cognitive Disorders, Vol. 15, No. 2, 2003, p. 55-66.

Research output: Contribution to journalArticle

@article{20f0a037a6364567b068cd2cf484ca1a,
title = "Dopaminergic modulation of visual-spatial working memory in Parkinson's disease",
abstract = "Visual-spatial working memory (WM) impairment is frequently associated with the early stage of Parkinson's disease (PD). The aim of this study was to evaluate the performance of a group of PD patients in visual-spatial and visual-object WM tasks and to investigate the effect of administering the dopaminergic agonist apomorphine (experiment 1) or the dopamine precursor L-dopa (experiment 2) on the performance of tests assessing these functions. To study WM processes, the PD patients and age-matched normal controls were given an n-back task paradigm. In both experiments, the PD patients were submitted to two evaluations: one after a 12-hour therapy washout and the other 15 min after a subcutaneous infusion of apomorphine (average 0.04 mg/kg) or 20/30 min after L-dopa intake (200 mg p.o.). The apomorphine infusion had a worsening effect on reaction times in both visual-spatial and visual-object WM tasks, but it did not influence performance accuracy. Instead, L-dopa administration had a ameliorative effect on accuracy and reaction times in both visual-spatial and visual-object tasks. These results highlight the role of dopamine in the modulation of the WM function in PD patients. Copyright",
keywords = "Apomorphine, Dopamine, Levodopa, Parkinson's disease, Working memory",
author = "Alberto Costa and Antonella Peppe and Grazia Dell'Agnello and Carlesimo, {Giovanni Augusto} and Luigi Murri and Ubaldo Bonuccelli and Carlo Caltagirone",
year = "2003",
doi = "10.1159/000067968",
language = "English",
volume = "15",
pages = "55--66",
journal = "Dementia and Geriatric Cognitive Disorders",
issn = "1420-8008",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Dopaminergic modulation of visual-spatial working memory in Parkinson's disease

AU - Costa, Alberto

AU - Peppe, Antonella

AU - Dell'Agnello, Grazia

AU - Carlesimo, Giovanni Augusto

AU - Murri, Luigi

AU - Bonuccelli, Ubaldo

AU - Caltagirone, Carlo

PY - 2003

Y1 - 2003

N2 - Visual-spatial working memory (WM) impairment is frequently associated with the early stage of Parkinson's disease (PD). The aim of this study was to evaluate the performance of a group of PD patients in visual-spatial and visual-object WM tasks and to investigate the effect of administering the dopaminergic agonist apomorphine (experiment 1) or the dopamine precursor L-dopa (experiment 2) on the performance of tests assessing these functions. To study WM processes, the PD patients and age-matched normal controls were given an n-back task paradigm. In both experiments, the PD patients were submitted to two evaluations: one after a 12-hour therapy washout and the other 15 min after a subcutaneous infusion of apomorphine (average 0.04 mg/kg) or 20/30 min after L-dopa intake (200 mg p.o.). The apomorphine infusion had a worsening effect on reaction times in both visual-spatial and visual-object WM tasks, but it did not influence performance accuracy. Instead, L-dopa administration had a ameliorative effect on accuracy and reaction times in both visual-spatial and visual-object tasks. These results highlight the role of dopamine in the modulation of the WM function in PD patients. Copyright

AB - Visual-spatial working memory (WM) impairment is frequently associated with the early stage of Parkinson's disease (PD). The aim of this study was to evaluate the performance of a group of PD patients in visual-spatial and visual-object WM tasks and to investigate the effect of administering the dopaminergic agonist apomorphine (experiment 1) or the dopamine precursor L-dopa (experiment 2) on the performance of tests assessing these functions. To study WM processes, the PD patients and age-matched normal controls were given an n-back task paradigm. In both experiments, the PD patients were submitted to two evaluations: one after a 12-hour therapy washout and the other 15 min after a subcutaneous infusion of apomorphine (average 0.04 mg/kg) or 20/30 min after L-dopa intake (200 mg p.o.). The apomorphine infusion had a worsening effect on reaction times in both visual-spatial and visual-object WM tasks, but it did not influence performance accuracy. Instead, L-dopa administration had a ameliorative effect on accuracy and reaction times in both visual-spatial and visual-object tasks. These results highlight the role of dopamine in the modulation of the WM function in PD patients. Copyright

KW - Apomorphine

KW - Dopamine

KW - Levodopa

KW - Parkinson's disease

KW - Working memory

UR - http://www.scopus.com/inward/record.url?scp=0037234962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037234962&partnerID=8YFLogxK

U2 - 10.1159/000067968

DO - 10.1159/000067968

M3 - Article

C2 - 12566593

AN - SCOPUS:0037234962

VL - 15

SP - 55

EP - 66

JO - Dementia and Geriatric Cognitive Disorders

JF - Dementia and Geriatric Cognitive Disorders

SN - 1420-8008

IS - 2

ER -